Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
019170.KS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-331.56
vs -226.25
Q1.23
N/A
-136.85
vs -107.62
Q2.23
N/A
-175.53
vs -92.93
Q3.23
N/A
-157.07
vs -188.78
Q4.23
N/A
-648.44
vs -331.56
Q1.24
N/A
-50.67
vs -136.85
Q2.24
N/A
-1.03
vs -175.53
Q3.24
N/A
-10.00
vs -157.07
Q4.24
N/A
-246.55
vs -648.44
Q1.25
+100%
NA
vs -50.67
Sales Growth
YoY
Current
Estimates
Q4.22
+18%
58.8B vs 49.7B
Q1.23
+3%
48.4B vs 46.8B
Q2.23
+5%
53.1B vs 50.4B
Q3.23
-8%
49.1B vs 53.4B
Q4.23
-16%
49.6B vs 58.8B
Q1.24
+12%
54B vs 48.4B
Q2.24
+5%
56B vs 53.1B
Q3.24
+14%
55.8B vs 49.1B
Q4.24
+11%
55.3B vs 49.6B
Q1.25
+3%
55.4B vs 54B
Return on Equity
QoQ
Q2.23
-3%
-0.03
vs -0.02
Q3.23
-3%
-0.03
vs -0.03
Q4.23
-12%
-0.12
vs -0.03
Q1.24
-1%
-0.01
vs -0.12
Q2.24
0%
-0.00
vs -0.01
Q3.24
0%
-0.00
vs -0.00
Q4.24
-5%
-0.05
vs -0.00
Q1.25
-1%
-0.01
vs -0.05
Institutionnal Ownership
Relative Strength
019170.KS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
KSC
Unprofitable
EPS improving
Unprofitable
EPS improving
-460.00Â ( -3.17%)
After-hours NaN$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-73%
Earning Acce
No
Dist 52w H.
31%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 019170.KS compares to sector?